247 related articles for article (PubMed ID: 9783766)
1. A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis.
Jessop JD; O'Sullivan MM; Lewis PA; Williams LA; Camilleri JP; Plant MJ; Coles EC
Br J Rheumatol; 1998 Sep; 37(9):992-1002. PubMed ID: 9783766
[TBL] [Abstract][Full Text] [Related]
2. Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two-year open randomized study.
Harth M; Davis P; Thompson JM; Menard H; Beaudet F
Scand J Rheumatol; 1987; 16(3):177-84. PubMed ID: 3110944
[TBL] [Abstract][Full Text] [Related]
3. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
Leonard PA; Bienz SR; Clegg DO; Ward JR
J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
[TBL] [Abstract][Full Text] [Related]
4. DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
Simon LS
Int J Clin Pract; 2000 May; 54(4):243-9. PubMed ID: 10912314
[TBL] [Abstract][Full Text] [Related]
5. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
[TBL] [Abstract][Full Text] [Related]
7. Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial. On behalf of the Rheumatic Research Foundation Utrecht, The Netherlands.
van Jaarsveld CH; Jacobs JW; van der Veen MJ; Blaauw AA; Kruize AA; Hofman DM; Brus HL; van Albada-Kuipers GA; Heurkens AH; ter Borg EJ; Haanen HC; van Booma-Frankfort C; Schenk Y; Bijlsma JW
Ann Rheum Dis; 2000 Jun; 59(6):468-77. PubMed ID: 10834865
[TBL] [Abstract][Full Text] [Related]
8. A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis.
Capell HA; Lewis D; Carey J
Ann Rheum Dis; 1986 Sep; 45(9):705-11. PubMed ID: 3094463
[TBL] [Abstract][Full Text] [Related]
9. Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials.
Dahl SL; Samuelson CO; Williams HJ; Ward JR; Karg M
Pharmacotherapy; 1990; 10(2):79-84. PubMed ID: 2112243
[TBL] [Abstract][Full Text] [Related]
10. Slow acting antirheumatic drugs in patients with juvenile rheumatoid arthritis--evaluated in a randomized, parallel 50-week clinical trial.
Kvien TK; Høyeraal HM; Sandstad B
J Rheumatol; 1985 Jun; 12(3):533-9. PubMed ID: 3930720
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
Vlak T; Stambuk B
Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
[TBL] [Abstract][Full Text] [Related]
12. Auranofin in rheumatoid arthritis: use in patients with side-effects or lack of effect to gold sodium thiomalate or gold thioglucose and/or D-penicillamine. A prospective one year investigation.
Manthorpe R; Tvede N; Bendixen G
Scand J Rheumatol; 1988; 17(5):401-5. PubMed ID: 3145556
[No Abstract] [Full Text] [Related]
13. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.
Wolfe F; Hawley DJ; Cathey MA
J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811
[TBL] [Abstract][Full Text] [Related]
14. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
[TBL] [Abstract][Full Text] [Related]
15. How reliable is ESR as a measure of disease activity in rheumatoid arthritis treated with hydroxychloroquine?
Dixon JS; Greenwood M; Bird HA
Clin Rheumatol; 1988 Jun; 7(2):262-6. PubMed ID: 2901304
[TBL] [Abstract][Full Text] [Related]
16. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
Batlle Gualda E
Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
[No Abstract] [Full Text] [Related]
17. Auranofin and gold sodium thiomalate in the treatment of rheumatoid arthritis: a one-year, double-blind, comparative multicenter study.
Schattenkirchner M; Bröll H; Kaik B; Müller-Fassbender H; Rau R; Zeidler H
Klin Wochenschr; 1988 Feb; 66(4):167-74. PubMed ID: 3131571
[TBL] [Abstract][Full Text] [Related]
18. [Gold compounds and D-penicillamine for therapy of rheumatoid arthritis].
Miyamoto S; Inoue T
Nihon Rinsho; 1992 Mar; 50(3):515-20. PubMed ID: 1588740
[TBL] [Abstract][Full Text] [Related]
19. Auranofin or D-penicillamine in the treatment of rheumatoid arthritis.
Hochberg MC
Ann Intern Med; 1986 Oct; 105(4):528-35. PubMed ID: 3092712
[TBL] [Abstract][Full Text] [Related]
20. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group.
Paulus HE; Egger MJ; Ward JR; Williams HJ
Arthritis Rheum; 1990 Apr; 33(4):477-84. PubMed ID: 2109613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
